Sign in

CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company

Evofem Biosciences, Inc.

Sign in to watch
Ticker
EVFM
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208527075
Phone
(858) 550-1900
Business address
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
Former names
Neothetics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-11-25 RMI Investments S.a.r.l. 10% owner Purchase +70,000 $14.00 $980K 1,585,549
2014-11-25 RMI Investments S.a.r.l. 10% owner Conversion · Series C Preferred Stock −9,244,852 0
2014-11-25 Gorbachev Maxim Director Conversion +1,515,549 1,515,549
2014-11-25 Gorbachev Maxim Director Purchase +70,000 $14.00 $980K 1,585,549
2014-11-25 Gorbachev Maxim Director Conversion · Series C Preferred Stock −9,244,852 0
2014-11-25 JANNEY DANIEL Director Conversion +122,951 126,885
2014-11-25 JANNEY DANIEL Director Conversion +1,161,939 1,288,824
2014-11-25 JANNEY DANIEL Director Conversion +476,845 1,765,669
2014-11-25 JANNEY DANIEL Director Conversion +735,912 2,501,581
2014-11-25 JANNEY DANIEL Director Option exercise +93,676 $11.29 $1.1M 2,595,257
2014-11-25 JANNEY DANIEL Director Sale −57,143 $14.00 $800K 2,538,114
2014-11-25 JANNEY DANIEL Director Option exercise +115,925 $8.54 $990K 2,654,039
2014-11-25 JANNEY DANIEL Director Sale −70,714 $14.00 $990K 2,583,325
2014-11-25 JANNEY DANIEL Director Option exercise +35,128 $8.54 $300K 2,618,453
2014-11-25 JANNEY DANIEL Director Sale −21,429 $14.00 $300K 2,597,024
2014-11-25 JANNEY DANIEL Director Purchase +70,000 $14.00 $980K 2,667,024
2014-11-25 JANNEY DANIEL Director Conversion · Seires A Preferred Stock −750,000 0
2014-11-25 JANNEY DANIEL Director Conversion · Series B Preferred Stock −6,216,215 0
2014-11-25 JANNEY DANIEL Director Conversion · Series B-2 Preferred Stock −2,201,220 0
2014-11-25 JANNEY DANIEL Director Conversion · Series C Preferred Stock −4,489,065 0

Page 19 of 20 · 383 trades